Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-03-26 | 2020-08-21 | 109595 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120890 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-09-24 | 2020-10-15 | 124995 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-01 | 2021-04-08 | 136759 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138300 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-06-17 | 2021-07-22 | 141113 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-08-27 | 2021-09-30 | 144760 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-09-30 | 2021-11-05 | 146469 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-10-07 | 2021-11-05 | 146856 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151468 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2022-01-27 | 2022-02-25 | 153727 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2022-06-09 | 2022-09-08 | 162303 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-02-16 | 2023-06-09 | 184934 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-06-16 | 2023-07-21 | 195039 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-06-16 | 2023-10-04 | 195055 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-07-27 | 2023-08-04 | 200210 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-08-17 | 2023-10-04 | 202228 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-12-14 | 2024-06-13 | 213368 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2024-03-07 | 2024-05-30 | 221540 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2024-08-30 | 2024-11-08 | 236362 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN SODIUM | 275MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258522 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258409 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258412 |
| TEVA-OLMESARTAN / HCTZ | 25MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258396 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258400 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258405 |
| TEVA-ONDANSETRON | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258774 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258729 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81313 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |